Avon Protection Plc

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: GB0000667013
GBP
17.94
-0.42 (-2.29%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Avon Protection Plc stock-summary
stock-summary
Avon Protection Plc
Pharmaceuticals & Biotechnology
Avon Rubber PLC is a United Kingdom-based technology company. The Company specializes in personal protection systems and milking point solutions through its two businesses, Avon Protection and milkrite InterPuls. The Company designs, tests and manufactures specialist products and services. Avon Protection provides respiratory and ballistic protection for the military, law enforcement and fire markets. milkrite InterPuls provides milking point solutions to customers across the world. The product range of Avon Protection includes respiratory and ballistic protection systems; chemical, biological, radiological and nuclear (CBRN) filters; mask platforms; powered air unit; CBRN powered air purifying respirator (PAPR); CBRN escape hood; air purifying escape hood; thermal imaging camera; ballistic helmets and body armor. The product range of milkrite InterPuls includes silicone tubing, Impulse Claw 300, calf nurser, electronic pulsators and milking point controller.
Company Coordinates stock-summary
Company Details
Semington Road, Hampton Park West , MELKSHAM None : SN12 6NB
stock-summary
Tel: 44 1225 896800
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (2.81%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Bruce Thompson
Non-Executive Independent Chairman of the Board
Mr. Paul McDonald
Chief Executive Officer, Executive Director
Mr. Nick Keveth
Chief Financial Officer, Executive Director
Mr. Victor Chavez
Non-Executive Independent Director
Ms. Bindi Foyle
Non-Executive Independent Director
Ms. Chloe Ponsonby
Non-Executive Independent Director
Dr. Pim Vervaat
Senior Non-Executive Independent Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

GBP 556 Million (Small Cap)

stock-summary
P/E

42.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

10.89%

stock-summary
Debt Equity

0.32

stock-summary
Return on Equity

10.41%

stock-summary
Price to Book

4.49